2 posts in this category
What’s actually changing for GLP-1 medications in 2026, what isn’t, and how new evidence is shaping care and expectations.
What Medicare, insurance, and federal policy signals really mean for GLP-1 coverage in 2026, including access rules, costs, and eligibility.